ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
Sara Russo(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), Sara Roggiani(University of Bologna), Fabrizia Carli(Istituto di Fisiologia Clinica), Maria Emiliana Caristo(Università Cattolica del Sacro Cuore), IVO BOSKOSKI, Rima Chakaroun(Sahlgrenska University Hospital), Vincenzo Bove(Agostino Gemelli University Polyclinic), Giulia Angelini(Università Cattolica del Sacro Cuore), Valentina Tremaroli(University of Gothenburg), Luca Proto(Agostino Gemelli University Polyclinic), Amalia Gastaldelli, Manoel Galvao Neto, Carel Le Roux, Samantha Pezzica(Istituto di Fisiologia Clinica), Stefan R Bornstein, Elena Previti(Università Cattolica del Sacro Cuore)
Cited by 0
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k